Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NDUFB4P10 is a **human pseudogene** related to the NADH:ubiquinone oxidoreductase subunit B4 protein, a component of mitochondrial Complex I[1]. As a pseudogene, it does not encode a functional protein; instead, its genomic sequence reflects an inactive copy derived from a related functional gene. Pseudogenes can have regulatory roles in the genome, such as producing noncoding RNAs that interact with regulatory networks, influencing gene expression, or acting as decoys for microRNAs[3][5]. However, there is no evidence specifically supporting a functional or therapeutic role for NDUFB4P10, and it is not considered an active, druggable, or canonical molecular target[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit B4 pseudogene 10 (NDUFB4P10).